ENHANCEMENT OF CORONARY VASODILATING ACTION OF ADENOSINE BY DILAZEP AND DIPYRIDAMOLE IN THE DOG
スポンサーリンク
概要
- 論文の詳細を見る
The mechanism of the augmentation of adenosine action by 1, 4-bis-[3(3, 4, 5-trimethoxybenzoyl-oxy)-propyl] perhydro-1, 4-diazepine (dilazep I, N, N, ) and dipyridamole on the coronary vessel was examined in the dog. Cororary blood flow was measured by applying a Morawitz cannula to the <I>in vivo</I> heart. It was found that the ratio of coronary vasodilating activity of adenosine administered into saphenous vein, right atrium, and left atrium was 1: 1.5: 30, and that coronary vasodilating actions of adenosine administered into saphenous vein, right atrium, and left atrium after dilazep (10 μg/kg, i.v.) were 15.6, 10.8, and 3.3 times greater than those without dilazep, respectively. After dipyridamole coronary vasodilating actions of adenosine administered into saphenous vein, right atrium, and left atrium were 17.5, 14.3, and 5.4 times greater. These results indicate that augmentation of coronary vasodilating action of intravenously administered adenosine by dilazep or dipyridamole was mainly exerted at the lung and myocardium, and slightly in the blood, and was due to inhibition of the disappearance of adenosine.
- 社団法人 日本薬理学会の論文
著者
-
Sano Nobuyuki
Departments Of Pediatric Surgery Tohoku University School Of Medicine
-
SANO Nobuyuki
Department of Pharmacology, Tokyo Research Laboratories, Kowa Company, Ltd.
-
SANO Nobuyuki
Department of Pharmacology, Tohoku University School of Medicine
関連論文
- E-cadherin, α-catenin and β-catenin in biliary atresia : Correlation with apoptosis and cell cycle
- The Outcome of Surgery for Biliary Atresia and the Current Status of Long-Term Survivors
- Clinical Significance of ^Tc-DTPA Galactosyl Human Serum Albumin Scintigram in Follow-up after Kasai Operation
- Abnormal Distribution of Nerve Fibers in the Liver of Biliary Atresia
- ENHANCEMENT OF CORONARY VASODILATING ACTION OF ADENOSINE BY DILAZEP AND DIPYRIDAMOLE IN THE DOG
- DIFFERENCES AMONG DIPYRIDAMOLE, CARBOCHROMEN AND LIDOFLAZINE IN RESPONSES OF THE CORONARY AND THE RENAL ARTERIES